Trevor M Penning

No ORCID on file · 12 papers in corpus
other 2024
Chemico-biological interactions ·doi:10.1016/j.cbi.2024.111111

The aldo-keto reductase (AKR) superfamily is a large family of proteins found across the kingdoms of life. Shared features of the family include 1) structural similarities such as an (α/β)8-barrel structure, disordered loop structure, cofac…

review 2020
Cancer drug resistance (Alhambra, Calif.) ·doi:10.20517/cdr.2020.60

Castration-resistant prostate cancer is the lethal form of prostate cancer and most commonly remains dependent on androgen receptor (AR) signaling. Current therapies use AR signaling inhibitors (ARSI) exemplified by abiraterone acetate, a P…

review 2019
Molecular and cellular endocrinology ·doi:10.1016/j.mce.2018.07.002

Aldo-Keto-Reductase 1C3 (type 5 17β-hydroxysteroid dehydrogenase (HSD)/prostaglandin (PG) F2α synthase) is the only 17β-HSD that is not a short-chain dehydrogenase/reductase. By acting as a 17-ketosteroid reductase, AKR1C3 produces potent a…

review 2019
Pharmacological research ·doi:10.1016/j.phrs.2019.104446

Endometriosis is a common gynecological disorder, which is treated surgically and/ or pharmacologically with an unmet clinical need for new therapeutics. A completed phase I trial and a recent phase II trial that investigated the steroidal …

review 2019
Endocrine Reviews ·doi:10.1210/er.2018-00089

Aldo-keto reductases (AKRs) are monomeric NAD(P)(H)-dependent oxidoreductases that play pivotal roles in the biosynthesis and metabolism of steroids in humans. AKR1C enzymes acting as 3-ketosteroid, 17-ketosteroid, and 20-ketosteroid reduct…

review 2017
Expert opinion on therapeutic patents ·doi:10.1080/13543776.2017.1379503

AKR1C3 is a drug target in hormonal and hormonal independent malignancies and acts as a major peripheral 17β-hydroxysteroid dehydrogenase to yield the potent androgens testosterone and dihydrotestosterone, and as a prostaglandin (PG) F synt…

review 2015
Chemico-biological interactions ·doi:10.1016/j.cbi.2014.09.024

The aldo-keto reductase (AKR) protein superfamily contains >190 members that fall into 16 families and are found in all phyla. These enzymes reduce carbonyl substrates such as: sugar aldehydes; keto-steroids, keto-prostaglandins, retinals, …

review 2014
Steroids ·doi:10.1016/j.steroids.2013.10.012

Human aldo-keto reductases AKR1C1-AKR1C4 and AKR1D1 play essential roles in the metabolism of all steroid hormones, the biosynthesis of neurosteroids and bile acids, the metabolism of conjugated steroids, and synthetic therapeutic steroids.…

other 2012
Journal of medicinal chemistry ·doi:10.1021/jm300841n

Human aldo-keto reductases 1C1-1C4 (AKR1C1-AKR1C4) function in vivo as 3-keto-, 17-keto-, and 20-ketosteroid reductases and regulate the activity of androgens, estrogens, and progesterone and the occupancy and transactivation of their corre…

review 2011
The Journal of steroid biochemistry and molecular biology ·doi:10.1016/j.jsbmb.2010.11.004

There is considerable interest in the development of an inhibitor of aldo-keto reductase (AKR) 1C3 (type 5 17β-hydroxysteroid dehydrogenase and prostaglandin F synthase) as a potential therapeutic for both hormone-dependent and hormone-inde…

other 2011
The Journal of steroid biochemistry and molecular biology ·doi:10.1016/j.jsbmb.2011.04.011
review 2004
Drug news & perspectives ·doi:10.1358/dnp.2004.17.9.872570

The human aldo-keto reductase 1C (AKR1C) isozymes are implicated in the pre-receptor regulation of steroid receptors, nuclear orphan receptors and membrane-bound ligand-gated ion channels. Human AKR members that may regulate the local conce…